» Articles » PMID: 34373583

Computational Estimates of Daily Aggregate Exposure to PFOA/PFOS from 2011 to 2017 Using a Basic Intake Model

Overview
Date 2021 Aug 10
PMID 34373583
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Human exposure to per- and polyfluoroalkyl substances has been modeled to estimate serum concentrations. Given that the production and use of these compounds have decreased in recent years, especially PFOA and PFOS, and that additional concentration data have become available from the US and other industrialized countries over the past decade, aggregate median intakes of these two compounds were estimated using more recent data.

Methods: Summary statistics from secondary sources were collected, averaged, and mapped for indoor and outdoor air, water, dust, and soil for PFOA and PFOS to estimate exposures for adults and children. European dietary intake estimates were used to estimate daily intake from food.

Results: In accordance with decreased concentrations in media, daily intake estimates among adults, i.e., 40 ng/day PFOA and 40 ng/day PFOS, are substantially lower than those reported previously, as are children's estimates of 14 ng/day PFOA and 17 ng/day PFOS. Using a first-order pharmacokinetic model, these results compare favorably to the National Health and Nutrition Examination Survey serum concentration measurements.

Conclusion: Concomitant blood concentrations support this enhanced estimation approach that captures the decline of PFOA/PFOS serum concentration over a decade.

Citing Articles

Linking exposure to per- and polyfluoroalkyl substances (PFAS) in house dust and biomonitoring data in eight impacted communities.

Minucci J, DeLuca N, Durant J, Goodwin B, Kowalski P, Scruton K Environ Int. 2024; 188:108756.

PMID: 38795657 PMC: 11323284. DOI: 10.1016/j.envint.2024.108756.


Effects of short-chain per- and polyfluoroalkyl substances (PFAS) on human cytochrome P450 (CYP450) enzymes and human hepatocytes: An study.

Solan M, Lavado R Curr Res Toxicol. 2023; 5:100116.

PMID: 37575337 PMC: 10412865. DOI: 10.1016/j.crtox.2023.100116.


A Scoping Assessment of Implemented Toxicokinetic Models of Per- and Polyfluoro-Alkyl Substances, with a Focus on One-Compartment Models.

East A, Dawson D, Brady S, Vallero D, Tornero-Velez R Toxics. 2023; 11(2).

PMID: 36851038 PMC: 9964825. DOI: 10.3390/toxics11020163.


Human exposure pathways to poly- and perfluoroalkyl substances (PFAS) from indoor media: A systematic review.

DeLuca N, Minucci J, Mullikin A, Slover R, Cohen Hubal E Environ Int. 2022; 162:107149.

PMID: 35240384 PMC: 11577573. DOI: 10.1016/j.envint.2022.107149.

References
1.
Barton K, Starling A, Higgins C, McDonough C, Calafat A, Adgate J . Sociodemographic and behavioral determinants of serum concentrations of per- and polyfluoroalkyl substances in a community highly exposed to aqueous film-forming foam contaminants in drinking water. Int J Hyg Environ Health. 2019; 223(1):256-266. PMC: 6878185. DOI: 10.1016/j.ijheh.2019.07.012. View

2.
Schwanz T, Llorca M, Farre M, Barcelo D . Perfluoroalkyl substances assessment in drinking waters from Brazil, France and Spain. Sci Total Environ. 2015; 539:143-152. DOI: 10.1016/j.scitotenv.2015.08.034. View

3.
Balk F, Putz K, Ribbenstedt A, Gomis M, Filipovic M, Cousins I . Children's exposure to perfluoroalkyl acids - a modelling approach. Environ Sci Process Impacts. 2019; 21(11):1875-1886. DOI: 10.1039/c9em00323a. View

4.
Thompson J, Lorber M, Toms L, Kato K, Calafat A, Mueller J . Use of simple pharmacokinetic modeling to characterize exposure of Australians to perfluorooctanoic acid and perfluorooctane sulfonic acid. Environ Int. 2010; 36(4):390-397. DOI: 10.1016/j.envint.2010.02.008. View

5.
Harada K, Saito N, Sasaki K, Inoue K, Koizumi A . Perfluorooctane sulfonate contamination of drinking water in the Tama River, Japan: estimated effects on resident serum levels. Bull Environ Contam Toxicol. 2003; 71(1):31-6. DOI: 10.1007/s00128-003-0126-x. View